You Searched For: 1,10-Phenanthroline monohydrate
692 results were found
~~media laboratory support~~
/m-at.vwr.com/de_AT/images/media_laboratory_support.pdf
Solutions made per month average vol.* 3550 l Unique media recipes 110 Range of vol. produced 100 ml - 500 l *Includes bulk and custom solutions. Totals listed above were current at time of publication. Output of VWRCATALYST Scientific Solutions L...
Stack up Single Sheet_VWR Europe_11-27-18
/m-at.vwr.com/de_AT/images/shenandoah_cytokines_flyer.pdf
Stack up Single Sheet_VWR Europe_11-27-18 Price: 10%-50% Savings SUPER competitive pricing on bulk orders. over other suppliers. Quality: Established for biological assays purity and endotoxin. Specific ED50s and specific activities are clearly li...
media laboratory support
/m-ch.vwr.com/it_CH/images/media_laboratory_support.pdf
Solutions made per month average vol.* 3550 l Unique media recipes 110 Range of vol. produced 100 ml - 500 l *Includes bulk and custom solutions. Totals listed above were current at time of publication. Output of VWRCATALYST Scientific Solutions L...
Stack up Single Sheet_VWR Europe_11-27-18
/m-pl.vwr.com/pl_PL/images/shenandoah_cytokines_flyer.pdf
Stack up Single Sheet_VWR Europe_11-27-18 Price: 10%-50% Savings SUPER competitive pricing on bulk orders. over other suppliers. Quality: Established for biological assays purity and endotoxin. Specific ED50s and specific activities are clearly li...
~~MK-TN-0010_REV_01_Streamlined_single-tube_solutions_0119~~
/m-ch.vwr.com/it_CH/images/MK-TN-0010-REV-01-Streamlined-single-tube-solution.pdf
MK-TN-0010_REV_01_Streamlined_single-tube_solutions_0119 Yi Jin Marissa Bolduc David Bays Shuhong Li Eleanor Kolossovski Brian Komorous Hongbo Liu and David Schuster Quantabio 100 Cummings Center Suite 407J Beverly MA 01915 Quantabio’s NGS Reagent...
~~A18L14A UHP SEC analysis of biosimilars~~
/m-in.vwr.com/en_IN/images/A18L14A_UHP_SEC_analysis_of_biosimilars.pdf
ANALYSIS APPLICATION NOTE INTRODUCTION A biosimilar is a biological medicine highly similar to an approved biological medicine (originator) in terms of structure biological activity and efficacy safety and immu- nogenicity profile. In order to dem...
A18L14A UHP SEC analysis of biosimilars
/m-ch.vwr.com/de_CH/images/A18L14A_UHP_SEC_analysis_of_biosimilars.pdf
ANALYSIS APPLICATION NOTE INTRODUCTION A biosimilar is a biological medicine highly similar to an approved biological medicine (originator) in terms of structure biological activity and efficacy safety and immu- nogenicity profile. In order to dem...
A18L14A UHP SEC analysis of biosimilars
/m-dk.vwr.com/da_DK/images/A18L14A_UHP_SEC_analysis_of_biosimilars.pdf
ANALYSIS APPLICATION NOTE INTRODUCTION A biosimilar is a biological medicine highly similar to an approved biological medicine (originator) in terms of structure biological activity and efficacy safety and immu- nogenicity profile. In order to dem...
~~A18L14A UHP SEC analysis of biosimilars~~
/m-cn.vwr.com/zh_CN/images/A18L14A_UHP_SEC_analysis_of_biosimilars.pdf
ANALYSIS APPLICATION NOTE INTRODUCTION A biosimilar is a biological medicine highly similar to an approved biological medicine (originator) in terms of structure biological activity and efficacy safety and immu- nogenicity profile. In order to dem...
A18L14A UHP SEC analysis of biosimilars
/m-no.vwr.com/no_NO/images/A18L14A_UHP_SEC_analysis_of_biosimilars.pdf
ANALYSIS APPLICATION NOTE INTRODUCTION A biosimilar is a biological medicine highly similar to an approved biological medicine (originator) in terms of structure biological activity and efficacy safety and immu- nogenicity profile. In order to dem...
A18L14A UHP SEC analysis of biosimilars
/m-es.vwr.com/es_ES/images/A18L14A_UHP_SEC_analysis_of_biosimilars.pdf
ANALYSIS APPLICATION NOTE INTRODUCTION A biosimilar is a biological medicine highly similar to an approved biological medicine (originator) in terms of structure biological activity and efficacy safety and immu- nogenicity profile. In order to dem...
A18L14A UHP SEC analysis of biosimilars
/m-pl.vwr.com/pl_PL/images/A18L14A_UHP_SEC_analysis_of_biosimilars.pdf
ANALYSIS APPLICATION NOTE INTRODUCTION A biosimilar is a biological medicine highly similar to an approved biological medicine (originator) in terms of structure biological activity and efficacy safety and immu- nogenicity profile. In order to dem...
A18L14A UHP SEC analysis of biosimilars
/m-de.vwr.com/de_DE/images/A18L14A_UHP_SEC_analysis_of_biosimilars.pdf
ANALYSIS APPLICATION NOTE INTRODUCTION A biosimilar is a biological medicine highly similar to an approved biological medicine (originator) in terms of structure biological activity and efficacy safety and immu- nogenicity profile. In order to dem...
A18L14A UHP SEC analysis of biosimilars
/m-at.vwr.com/de_AT/images/A18L14A_UHP_SEC_analysis_of_biosimilars.pdf
ANALYSIS APPLICATION NOTE INTRODUCTION A biosimilar is a biological medicine highly similar to an approved biological medicine (originator) in terms of structure biological activity and efficacy safety and immu- nogenicity profile. In order to dem...
Hichrom International Catalogue 9 33 57
/m-si.vwr.com/sl_SI/images/Hichrom_International_Catalogue_9_33_57.pdf
33 LC Colum n Selection – C18 Reversed-Phase M aterials www.hichrom.co.uk • sales@hichrom.co.uk • Tel: +44 (0) 118 930 3660 Hichrom Lim ited C18 Reversed-Phase Materials SPECIFICATIONS OF C18 BONDED RP MATERIALS Octadecyl (ODS) or C18 bonded phase...
A18L14A UHP SEC analysis of biosimilars
/m-pt.vwr.com/pt_PT/images/A18L14A_UHP_SEC_analysis_of_biosimilars.pdf
ANALYSIS APPLICATION NOTE INTRODUCTION A biosimilar is a biological medicine highly similar to an approved biological medicine (originator) in terms of structure biological activity and efficacy safety and immu- nogenicity profile. In order to dem...
225 - 240 of 692